KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Net Margin (2016 - 2025)

Historic Net Margin for Xenon Pharmaceuticals (XENE) over the last 11 years, with Q1 2025 value amounting to 867.29%.

  • Xenon Pharmaceuticals' Net Margin changed N/A to 867.29% in Q1 2025 from the same period last year, while for Sep 2025 it was 4269.19%, marking a year-over-year change of. This contributed to the annual value of 1324.32% for FY2022, which is 9062100.0% down from last year.
  • According to the latest figures from Q1 2025, Xenon Pharmaceuticals' Net Margin is 867.29%.
  • In the past 5 years, Xenon Pharmaceuticals' Net Margin ranged from a high of 220.98% in Q1 2022 and a low of 28143.94% during Q3 2022
  • Over the past 3 years, Xenon Pharmaceuticals' median Net Margin value was 769.17% (recorded in 2021), while the average stood at 4672.1%.
  • Over the last 5 years, Xenon Pharmaceuticals' Net Margin had its largest YoY gain of 1310400bps in 2022, and its largest YoY loss of -278087600bps in 2022.
  • Over the past 3 years, Xenon Pharmaceuticals' Net Margin (Quarter) stood at 671.05% in 2021, then tumbled by -4094bps to 28143.94% in 2022, then surged by 97bps to 867.29% in 2025.
  • Its last three reported values are 867.29% in Q1 2025, 28143.94% for Q3 2022, and 5813.06% during Q2 2022.